Find, compare & contact
Ezogabine
API Manufacturers & Suppliers
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Follow us
Distributor
Produced in:
Established in: 2011
MOQ: 10 g
Employees: 10+
Fast Response and Good Communication
Willingness To Start From Small
Flexible Payment Terms
+ 0
All certificates
Produced in:
Established in: 2008
MOQ: 1 kg
Employees: 300+
More than 150 patents based on independent intelligence
Expertise in anti-tumor, anti-diabetes and cardiovascular API and intermediates.
GMP facility with annual production capacity of 300M
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Ezogabine API 150812-12-7?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Ezogabine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Ezogabine
- Synonyms:
- EZG , Potiga , Retigabine , RTG
- Cas Number:
- 150812-12-7
- DrugBank number:
- DB04953
- Unique Ingredient Identifier:
- 12G01I6BBU
About Ezogabine
Why are professionals looking for Ezogabine? Ezogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in adult patients with refractory epilepsy. FDA approved in June 2011 under the name of ezogabine.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Ezogabine is a type of Antiepileptics
Antiepileptics, also known as antiseizure or anticonvulsant drugs, belong to the pharmaceutical category of active pharmaceutical ingredients (APIs) used for the treatment of epilepsy and other seizure disorders. These medications work by modulating the activity of neurotransmitters and ion channels in the brain to prevent or reduce the occurrence of seizures.
Antiepileptic APIs are classified into various chemical classes, including hydantoins, barbiturates, benzodiazepines, succinimides, and others. Each class of antiepileptics exerts its therapeutic effects through distinct mechanisms, targeting different components of the brain's neural network involved in seizure generation and propagation.
These APIs are typically formulated into oral tablets, capsules, or liquids for easy administration. Some antiepileptic drugs are also available in injectable forms for emergency situations. The dosage and treatment duration vary based on the patient's age, seizure type, and medical history.
The development of antiepileptic APIs requires rigorous research, including preclinical and clinical trials, to establish safety, efficacy, and optimal dosing regimens. Pharmaceutical companies follow strict quality control standards to ensure the purity, stability, and consistent quality of these APIs.
While antiepileptics are primarily used for epilepsy management, they are also prescribed for other neurological conditions such as bipolar disorder, neuropathic pain, and migraine prophylaxis. However, it is important to note that these medications may have potential side effects, including drowsiness, dizziness, cognitive impairment, and mood changes, which should be carefully monitored by healthcare professionals.
In conclusion, antiepileptics represent a crucial category of pharmaceutical APIs utilized in the treatment of epilepsy and other seizure disorders. These drugs play a vital role in managing and improving the quality of life for individuals affected by these conditions, helping to reduce the frequency and severity of seizures.
Ezogabine manufacturers | traders | suppliers
We have 2 companies offering Ezogabine produced in 1 different countries.
Get in contact with the supplier of your choice:
- Shandong Octagon Chemicals Limited from China, product country of origin China
- Tianjin Pharmacn Medical Technology Co., ltd from China, product country of origin China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
